New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABT;FB;ALDW;ALJ;LRCX;WES;ABBV;WGP;WHF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 20, 2015
06:57 EDTFBFacebook to upgrade Messenger app, experiment with revenue generation, WSJ says
Subscribe for More Information
06:02 EDTFBFacebook acquires boutique firm Teehan+Lax, terms not disclosed
Toronto-based boutique firm Teehan+Lax announced in a blog post on Friday that the company will join Facebook's design team in California. T+L said "In a few weeks we will be moving to the San Francisco Bay Area. This will mean saying goodbye to family, friends, Toronto, and Teehan+Lax." Terms of the deal have not been disclosed. Reference Link
January 18, 2015
16:34 EDTFBFacebook job listings hint at push into virtual reality, Reuters says
Subscribe for More Information
January 16, 2015
10:10 EDTABBVAbbVie announces FDA approval of DUOPA enteral suspension
Subscribe for More Information
07:40 EDTALJWolfe Research to hold a conference
1st Annual Oil & Gas 1:1 Refining Conference is being held in Boston on January 16.
07:04 EDTABBVEnanta says EU grants marketing authorizations for AbbVie's Viekirax
Subscribe for More Information
05:05 EDTABBVAbbVie granted marketing authorization by EC for VIEKIRAX + EXVIERA
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX + EXVIERA. The treatment has been approved with or without ribavirin for patients with genotype 1 chronic hepatitis C virus infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.1,2 Additionally, VIEKIRAX has been approved for use with RBV in genotype 4 chronic hepatitis C patients.
January 15, 2015
11:20 EDTABBVGoldman cuts J&J to sell citing competitive pressures
Subscribe for More Information
January 14, 2015
12:25 EDTABBVAbbVie says pipeline is 'most robust it's ever been'
12:09 EDTABBVAbbVie says 'strongly' committed to dividend, returning cash to shareholders
Subscribe for More Information
12:00 EDTABBVAbbVie says guidance to be further refined as HCV launch progresses
11:59 EDTABBVAbbVie repeats FY15 adjusted EPS view $4.25-$4.45, consensus $4.30
Subscribe for More Information
10:27 EDTFBFacebook, Google seen at front of 'multi-year' positive run for Internet stocks
Subscribe for More Information
09:46 EDTFBFacebook initiated with a Buy at Rosenblatt
Target $100.
07:17 EDTFBFacebook price target raised to $100 from $88 at Oppenheimer
Subscribe for More Information
07:13 EDTFBFacebook price target raised to $102 on FAN contribution at Credit Suisse
Credit Suisse raised Outperform rated Facebook's price target to $102 from $88 to reflect new mobile ad network FAN into its estimates. The analyst expects Premium Video to have a greater impact on 2015 financials and longer-term for new products and yet-to-be monetized properties to continue to drive estimates.
January 13, 2015
12:15 EDTABBVExpress Scripts CEO says Gilead relationship 'important' going forward
Express Scripts (ESRX) CEO George Paz at the J.P. Morgan Healthcare Conference said his company's relationship with Gilead (GILD) is "important" going forward. Paz said his company's goal is not to exclude drugs. He continues to discuss Express Scripts's deal with AbbVie (ABBV) and the company's goal of saving clients money with regards to healthcare costs.
11:42 EDTFBJustice Department partners with Facebook, Bing to expand reach of AMBER Alerts
Subscribe for More Information
10:00 EDTABTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:57 EDTABTAbbott downgraded to Hold from Buy at Jefferies
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use